Business news – Page 68
-
NewsBig business backs White House on climate change
Top US companies including Google, Apple and Coca-Cola pledge at least $140 billion in new low-carbon investments
-
Business
Celgene to buy immune-inflammatory specialist Receptos
$7.2bn deal further strengthens Celgene’s position in immunology
-
Business
Hikma boosts generics with Roxane buyout
Acquiring the Boehringer Ingelheim subsidiary expands Hikma’s presence in US generics market
-
Business
Allergan steps away from generics with sale to Teva
$40.5 billion deal gives Allergan cash to clear debt and fund further acquisitions, and catapults Teva into global pharma top 10
-
Business
Biogen to develop gene therapies with AGTC
$1bn deal gives Biogen rights to one clinical candidate and several earlier-stage programmes for rare eye diseases
-
Business
Three dead in Chinese petrochemical plant fire
Further four workers injured after leaking oil ignited at Qingyang Petrochemical plant in Gansu province
-
BusinessUS regulator says DuPont’s safety programme ‘failed’
The US Occupational Safety and Health Administration has again proposed to fine DuPont after uncovering ‘repeated’ and ‘serious’ lapses in the company’s worker safety programme
-
Opinion
Taking responsibility seriously
Companies have a duty to be proactive when it comes to sustainability
-
BusinessChemical firms seek better grasp of biomanufacturing
The search is on for better alternatives to the ‘broken’ way companies harness compound-making organisms
-
BusinessAn unsustainable hypocrisy
Social responsibility should extend through the whole supply chain, not just be a tool to put pressure on feedstock suppliers
-
NewsUS chemical industry lobby group in the hot seat again
Union of Concerned Scientists calls for greater transparency in the political activities of American Chemistry Council and member companies
-
Business
US import ban imposed on Indian pharma firm
Concerns over manufacturing processes at Emcure facility prompts Food and Drug Administration to block drug shipments
-
Business
US chemical maker Platform expands with Alent purchase
Platform Specialty Products plans to enlarge its scope and reach by acquiring British chemicals firm Alent for $2.1bn
-
Business
Celgene backs immunotherapy with Juno collaboration
$1bn investment in 10-year CAR-T cell partnership for cancer treatments
-
Business
Thermo Fisher to buy Alfa Aesar chemical supplies
Research chemicals business no longer a strategic fit for owner Johnson Matthey
-
Business
Blast kills six at South Korean chemical plant
One further worker injured as tank explodes during welding work
-
FeaturePharma queues up for checkpoint inhibitor collaborations
Combinations of different firms’ drugs seek to reap immuno-oncology’s benefits
-
Business
Job cuts at Allergan and Transgene
Allergan is shedding 300 staff at former Actavis site in Iceland, while Transgene is closing its French manufacturing plant with loss of 120 jobs
-
NewsBP emerges from Deepwater with $18.7bn settlement
BP has agreed to pay an $18.7 billion settlement to five states damaged by the Deepwater Horizon oil spill
-
Business
Fracking prohibited in New York state and Lancashire
Local US and UK rulings prohibit shale oil drilling and exploration